Acquisition of Software for Whole-Genome Sequencing
Overview
Fit Score
Settle Intelligence
Settle helps teams find, evaluate, and respond to public RFPs. We continuously surface new opportunities, score them against your company strengths, and draft proposal responses so you can focus on the work that wins business.
SUMMARY
DESCRIPTION
The National Institutes of Health (NIH), National Cancer Institute (NCI), Integrative Tumor Epidemiology Branch (ITEB) seeks to procure the annual renewal of one Sentieon software license for whole-genome sequencing. This license renewal is essential for facilitating high-speed, accurate variant detection within large tumor cohorts, a critical component of ongoing cancer genomics research.
The Sentieon software provides a 20–50 fold increase in processing speed compared to existing solutions, without compromising accuracy. Its proprietary nature and performance characteristics enable ITEB to accelerate research workflows while efficiently managing computational resources. The renewal will ensure continued support for planned projects and maintain cost efficiency for the federal government. Interested parties able to meet these requirements may submit capability statements for consideration, with responses due by 2:00 PM EST, March 2, 2026.
Source attribution
This Settle analysis is based on the issuing organization’s public RFP listing.